Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Iguratimod 25mg Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹339/-
Iguhype 25 Tablet is a medicine used for the treatment of rheumatoid arthritis, a long-term condition that causes pain, swelling, and stiffness in the joints. It works by reducing inflammation and controlling the overactive immune response that damages the joints. By taking this medicine regularly, it can help relieve pain, improve movement, and prevent further joint damage over time. This makes daily activities like walking, holding objects, or bending the joints easier and less painful. It is usually prescribed for long-term use and may be taken alone or with other arthritis medicines as advised by the doctor.
Common side effects include nausea, abdominal discomfort, diarrhea, headache, and mild liver enzyme elevation. Some patients may experience skin rash or pruritus. Rare but serious adverse effects include significant hepatotoxicity, leukopenia, thrombocytopenia, and severe allergic reactions. Periodic monitoring of liver function tests and blood counts is essential during therapy.
Iguhype 25 Tablet is indicated for the management of rheumatoid arthritis to relieve pain, stiffness, and swelling, and to slow disease progression. It may also be prescribed off-label in other autoimmune inflammatory arthropathies under specialist supervision.
Iguhype 25 Tablet should only be taken under the supervision of a rheumatologist or physician experienced in managing RA. Baseline and periodic liver function and blood tests are mandatory during treatment. It is contraindicated in patients with severe hepatic impairment, active infections, or known hypersensitivity to Iguratimod. Caution is advised in individuals with gastrointestinal ulcers or bone marrow suppression. It should not be used during pregnancy or lactation unless the potential benefit outweighs the risk, as safety data is limited. Live vaccines should be avoided during therapy due to immunosuppressive effects. Dose adjustments or discontinuation may be necessary if significant adverse reactions occur.
Store Iguhype 25 Tablet in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep in its original blister packaging and out of reach of children. Do not use after the expiry date printed on the pack.
Composition : Leflunomide (10mg) Tablet
Composition : Leflunomide (20mg)
Composition : Tofacitinib (5mg)
Composition : Azathioprine 50mg Tablet
Composition : Diacerein (50mg) + Glucosamine Sulfate Potassium Chloride (750mg) + Methyl Sulfonyl Methane (250mg)
Composition : Boswellia Serrata 350mg + Vitax Negundo 250mg Tablet
Composition : Bromelain (180mg) + Trypsin (96mg) + Rutoside (200mg)
Composition : Oxaceprol (200mg) Capsule
Composition : Diacerein 50mg Capsule
Composition : Rose Hip Extract 250mg + Collagen Peptide Type-2 40mg + Sodium Hyaluronate 30mg + Vitamin C 35mg + Chondroitin 200mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation